|
DENND5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.066200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.503590E-01 |
| Normal-vs-Stage2 |
4.257400E-01 |
| Normal-vs-Stage3 |
7.937200E-01 |
| Normal-vs-Stage4 |
9.318200E-01 |
| Stage1-vs-Stage2 |
7.286600E-01 |
| Stage1-vs-Stage3 |
2.890200E-01 |
| Stage1-vs-Stage4 |
3.261000E-01 |
| Stage2-vs-Stage3 |
6.250800E-01 |
| Stage2-vs-Stage4 |
5.702400E-01 |
| Stage3-vs-Stage4 |
7.990000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.920600E-01 |
| Normal-vs-AfricanAmerican |
3.598400E-01 |
| Normal-vs-Asian |
2.281200E-01 |
| Caucasian-vs-AfricanAmerican |
8.401400E-01 |
| Caucasian-vs-Asian |
5.543800E-01 |
| AfricanAmerican-vs-Asian |
4.572200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.848360E-01 |
| Normal-vs-Female |
8.059200E-01 |
| Male-vs-Female |
1.700020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.748380E-01 |
| Normal-vs-Extreme_Weight |
3.196200E-02 |
| Normal-vs-Obese |
8.639600E-01 |
| Normal-vs-Extreme_Obese |
1.717180E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.699200E-01 |
| Normal_Weight-vs-Obese |
1.756170E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.236600E-01 |
| Extreme_Weight-vs-Obese |
2.474200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.897400E-01 |
| Obese-vs-Extreme_Obese |
2.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.564000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.758400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.045410E-01 |
| Normal-vs-Age(81-100Yrs) |
1.230800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.679800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.579900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.765600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.728200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.452200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.607800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.373200E-01 |
| Normal-VS-Type2 PRCC |
2.601800E-01 |
| Normal-VS-KIRP CIMP |
3.127000E-01 |
| Normal-VS-Unclassified PRCC |
7.469400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.935000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.499360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.952560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.092400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.619580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.744200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.976050E-01 |
| Normal-vs-N1 |
4.490000E-01 |
| Normal-vs-N2 |
1.452430E-01 |
| N0-vs-N1 |
6.833900E-02 |
| N0-vs-N2 |
7.139600E-02 |
| N1-vs-N2 |
3.794400E-01 |
|
|
